Caspofungin Acetate

3 trials 1 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

9 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Oversight events:

7 temporary halts across 1 trial

View oversight register →

Indications tested

Aspergillus infection 1 Scedosporium infection 1 Fusarium infection 1 Fungal infection 1

Sponsors using this IMP

Basilea Pharmaceutica International AG Allschwil 1 Scynexis Inc. 1 University Of Cologne 1

All trials

3 total

A multicenter, randomized, double-blind, placebo-controlled, adaptive, non-inferiority trial to investigate shortening treatment duration in… Pending

2026-525640-14-00 Phase IV 1 country University Of Cologne
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus I… Ended

2024-511755-18-00 Phase III 7 countries Scynexis Inc.

Showing 1–3 of 3 trials

← All drugs A–Z